FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – Europe 09/2024”. The Monitor is a month-to-month revealed overview of enterprise capital developments within the European Healthcare & Life Sciences sector.
As of the top of September 2024 we recognized the next present VC developments in Europe:
- Whole Healthcare & Life Sciences funding reached EUR 6,507m
- Biotech/Pharma obtained 60% of the entire funding quantity (EUR 3,939m) with oncology being the main indication (46%)
- In September, Pantera (Belgium) secured the best transaction quantity with EUR 134m, adopted by F2G (United Kingdom) with EUR 90m and ViceBio (United Kingdom) with EUR 90m
- Basic Atlantic (United States) is essentially the most energetic investor (by deal quantity in 2024), adopted by European Innovation Council Fund (Belgium) and Forbion (Netherlands)
To entry the complete report, please click on right here.
